glp-1 drug market Drugs Size to Hit USD 132.79 Bn by 2035 GLP-1 Drug Market: the rapid
Description
10.1016/j.ijpharm.2025.125319
doi: 10.1038/ijo.2011.158 57 PetrovicAIgrecDRozacKBojanicKKunaLKolaricTOet al
We ensure accurate diagnosis to recommend the appropriate treatment
Chong, B
Obesity is associated with several cardiometabolic complications, which reduce the quality of life as well as life expectancy
[4] These gastrointestinal symptoms are often mild to moderate in severity and tend to diminish over time as the body adjusts to the medication
